Concepedia

Junyou Ge

JG

Statistics

Publications

15

Citations

406

H-Index

12

Active since

2023

Affiliations

Kelun Group (China)(Current)

Hunan Cancer Hospital

Sun Yat-sen University

Sun Yat-sen University Cancer Center

Shandong First Medical University

Junyou Ge is an author at Kelun Group (China) specializing in oncology, cancer pharmacology, and pharmacology.

Publications per year

2023–2025

15

Publications

15

Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours

Jian Zhang, Rujiao Liu, Shuiping Gao et al. · npj Breast Cancer · 2023 · 54 citations · Full text

, , +17

Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study.

Binghe Xu, Yongmei Yin, Ying Fan et al. · Journal of Clinical Oncology · 2024 · 45 citations

, , +17

Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial

Yongmei Yin, Ying Fan, Quchang Ouyang et al. · Nature Medicine · 2025 · 45 citations

, , +14

Sacituzumab Tirumotecan in EGFR-TKI–Resistant, <i>EGFR</i> -Mutated Advanced NSCLC

Wenfeng Fang, Lin Wu, Xiangjiao Meng et al. · New England Journal of Medicine · 2025 · 40 citations

, , +17

Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials

Shen Zhao, Ying Cheng, Qiming J. Wang et al. · Nature Medicine · 2025 · 39 citations

, , +17

1–5 of 15